Upstate Active Clinical Trials

Study Title:

RTOG 0839: Randomized Phase II Study of Pre-operative Chemoradiotherapy +/- Panitumumab (IND #110152) Followed by Consolidation Chemotherapy +/- Cetuximab in Potentially Operable Locally Advanced (Stage IIIA, N2+) Non-Small Cell Lung Cancer

What is the purpose of the study?

This randomized phase II trial is studying chemotherapy and radiation therapy to see how well they work when given with or without panitumumab in treating patients with stage IIIA non-small cell lung cancer.

Upstate Institutional Review Board (IRB) Number:

321567

Study Phase:

II

Patient Age Group:

Adults

Principal Investigator:

Jeffrey A Bogart, MD

ClinicalTrials.Gov ID:

NCT00979212

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Dena R Martin
Phone: 315-464-5262
Email: martind@upstate.edu

Return to Previous Page || Search Again